Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

R. Donald Harvey, PharmD (he/him/his)

Professor
Emory Univ School of Medicine

R. Donald Harvey III, PharmD, BCOP, FCCP, FHOPA, FASCO
Professor
Departments of Hematology and Medical Oncology and Pharmacology
Emory University School of Medicine
Vice President, Clinical Research
Woodruff Health Sciences Center
Atlanta, Georgia

Donald received his BS and PharmD degrees from the University of North Carolina (UNC) at Chapel Hill. He completed a pharmacy practice residency at the University of Kentucky Medical Center and College of Pharmacy and a hematology/oncology specialty residency at UNC Hospitals and School of Pharmacy.

He has over 150 peer-reviewed publications and has been a principal or co-investigator on over 120 early phase clinical trials. Dr. Harvey is on the editorial board of Clinical Pharmacology and Therapeutics, Cancer Chemotherapy and Pharmacology, and Pharmacotherapy. Donald is a past president of the Hematology Oncology Pharmacy Association and past chair of the Research committee of the American Society of Clinical Oncology (ASCO). His research focuses on the application of clinical pharmacology principles to improve cancer treatment outcomes, and, more recently, improvements in anticancer drug development dose derivation processes and clinical trial inclusion.

Disclosure information not submitted.

Presentation(s):